Congruence Therapeutics
Montréal
About Congruence Therapeutics
Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $141.1M
- Last round: Series Unknown (Mar 2026)
- Website: congruencetx.com
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/congruence-therapeutics-76699 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.